Sumatriptan and cerebral blood flow velocity changes during migraine attacks
- PMID: 9439084
- DOI: 10.1046/j.1526-4610.1997.3710635.x
Sumatriptan and cerebral blood flow velocity changes during migraine attacks
Abstract
Transcranial Doppler studies on the effects of sumatriptan on cerebral hemodynamics have shown conflicting results. We evaluated blood flow velocity changes in 21 patients suffering from migraine with (n = 4) or without aura (n = 17) during a spontaneous attack, before and after treatment with sumatriptan. Flow velocity in the internal and external carotid, middle cerebral, and basilar arteries was measured by means of transcranial Doppler. During the attack, measurements were taken before subcutaneous sumatriptan injection, then after 30 minutes, 2 hours, and 24 hours. An additional measurement was taken 1 week later, in a headache-free state. We found a significant reduction of flow velocity during the attack in the middle cerebral artery on both sides (P < 0.05). After sumatriptan administration, flow velocity increased in the internal carotid artery on both sides (P < 0.05) and in the middle cerebral artery on the headache side (P = 0.0001), but not in the external carotid and basilar arteries (P > 0.05). Flow velocity changes may reflect the vasodilation present at the onset of the migraine attack followed by vasoconstriction in the internal carotid and middle cerebral arteries after sumatriptan treatment. Since vasoconstriction occurs in responders and nonresponders to treatment, it is unlikely to be the primary mechanism by which sumatriptan relieves headache.
Similar articles
-
[Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background subtraction method].No To Shinkei. 2001 Jul;53(7):625-30. No To Shinkei. 2001. PMID: 11517486 Japanese.
-
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.Neurology. 1992 Aug;42(8):1522-6. doi: 10.1212/wnl.42.8.1522. Neurology. 1992. PMID: 1322512 Clinical Trial.
-
Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.J Neurol. 1991 Aug;238(5):245-50. doi: 10.1007/BF00319734. J Neurol. 1991. PMID: 1655985
-
Sumatriptan. An updated review of its use in migraine.Drugs. 1998 Jun;55(6):889-922. doi: 10.2165/00003495-199855060-00020. Drugs. 1998. PMID: 9617601 Review.
-
5-HT(1)-like receptor agonists and the pathophysiology of migraine.Trends Pharmacol Sci. 1989 May;10(5):200-4. doi: 10.1016/0165-6147(89)90238-1. Trends Pharmacol Sci. 1989. PMID: 12722735 Review.
Cited by
-
Chemical mediators of migraine: preclinical and clinical observations.Headache. 2011 Jun;51(6):1029-45. doi: 10.1111/j.1526-4610.2011.01929.x. Headache. 2011. PMID: 21631491 Free PMC article. Review.
-
Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms.J Headache Pain. 2010 Oct;11(5):379-89. doi: 10.1007/s10194-010-0232-1. Epub 2010 Jul 7. J Headache Pain. 2010. PMID: 20607582 Free PMC article. Review.
-
Transcranial Doppler measurements in migraine and nitroglycerin headache.J Headache Pain. 2007 Oct;8(5):289-93. doi: 10.1007/s10194-007-0413-8. Epub 2007 Oct 23. J Headache Pain. 2007. PMID: 17955171 Free PMC article.
-
Cerebral Hemodynamic Changes During Migraine Attacks and After Triptan Treatments.Noro Psikiyatr Ars. 2019 Feb 12;57(3):192-196. doi: 10.29399/npa.21650. eCollection 2020 Sep. Noro Psikiyatr Ars. 2019. PMID: 32952420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous